SCHEMBL5063247

SCHEMBL5063247

O=C(O)N1Cc2ccccc2NC[C@H]1COCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1D1 P20393 1/20 0.48
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
LMNA P02545 1/20 0.41
AGTR2 P50052 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ABHD6 Q9BV23 1/20 0.37
DAGLA Q9Y4D2 1/20 0.37
NAMPT P43490 1/20 0.37
PARP1 P09874 1/20 0.36
DPP4 P27487 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
HTR2C P28335 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5068055 0.81 MTNR1A (0.40) MEN1KMT2AACHEPRMT5WDR77
SCHEMBL11890095 0.81 MTNR1A (0.40) MEN1KMT2AACHEPRMT5WDR77
SCHEMBL20873266 0.75 CA1 (0.46) NR1D1LMNAAGTR2ABHD6DAGLA
SCHEMBL875040 0.75 CA1 (0.46) NR1D1LMNAAGTR2ABHD6DAGLA
SCHEMBL22208106 0.75 NR1D1 (0.51) NR1D1OPRM1OPRD1OPRK1LMNA
SCHEMBL22554973 0.75 NR1D1 (0.51) NR1D1OPRM1OPRD1OPRK1LMNA
SCHEMBL5066726 0.72 MTNR1A (0.42) MEN1KMT2AHTR2CGAAMAPK1
SCHEMBL6360197 0.70 ABHD6 (0.56) NR1D1ABHD6DAGLADPP4
SCHEMBL15811762 0.70 ABHD6 (0.56) NR1D1ABHD6DAGLADPP4
SCHEMBL19617254 0.70 ABHD6 (0.56) NR1D1ABHD6DAGLADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these AVPR2, UTS2R, GPR119 NR1D1 214/4885OPRM1 8/4885OPRD1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.